Skip to content
Trial Eligibility
Menu

Light Therapy Intervention in Individuals With Parkinson's Disease

NCT06916260

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The study looks to investigate the effects that light therapy delivered to the frontal cortex could have on Parkinson's disease related symptoms ( both cognitive and motor). The therapy is a non invasive technique that deliverers low level wavelength light to the front part of the head for 12 minutes. for this study the therapy will be done 3 times a week for 6 weeks.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Parkinson Disease

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
50 to 80 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
University of Delaware
Last updated on ClinicalTrials.gov
April 8, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Delaware · 1

  • University of Delaware STAR Tower · Newark, DE

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.